Skip to content
← Full study record

NCT04840615 · MORE INFO

Limitations, agreements, and source contact

Intratumor Injection of Anti-Mesothelin Immunotoxin LMB-100 With Ipilimumab in Malignant Mesothelioma · Source last updated 2024-02-02

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
point Of Contact
email
rh276q@nih.gov
organization
National Cancer Institute
phone
240760-6232
title
Dr. Raffit Hassan
Complete source fields
certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
point Of Contact
email
rh276q@nih.gov
organization
National Cancer Institute
phone
240760-6232
title
Dr. Raffit Hassan

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice